BMI Korea
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj. Health, Subjective | Phase 1 | 2022-06-30 |
| Completed | Treatment of Moderate to Severe Glabellar Lines (BMI2006) Glabellar Lines | Phase 3 | 2021-02-09 |